James E. Thomas

Biography

 James is a co-founder of Thomas, McNerney & Partners and has been investing in health care companies since 1992.  Prior to joining Warburg, James was a Vice President at Goldman Sachs International in London. He is currently a board member of CAS Medical Systems, Inc. (CASM), Clarus Therapeutics, Inc.  and Keystone Dental, Inc.. Historical investments include: American Medical Systems Holdings, Inc. (AMMD), Coley Pharmaceutical Group, Inc. (COLY sold to Pfizer), Galil Medical Ltd. (sold to BTG plc), The Medicines Company (MDCO),  OsteoBiologics, Inc. (sold to Smith & Nephew plc),  Torax Medical, Inc. (sold to Johnson and Johnson), Transkaryotic Therapies, Inc. (TKTX sold to Shire Pharmaceuticals Group plc),  Wright Medical Group, Inc. (WMGI), and Xomed Surgical Products, Inc. (XOMD sold to Medtronic, Inc.). James graduated magna cum laude with a B.S. in Economics from the Wharton School at the University of Pennsylvania and received an M.Sc. in Economics from the London School of Economics.

Research Interest

 James previously headed Warburg Pincus LLC's medical technology private equity practice, where he had responsibility for investments in biotechnology, pharmaceutical, medical device and diagnostic companies.